Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.9 USD | -0.03% | +1.51% | -2.92% |
12:29am | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 185B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.58 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 913M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
31.2
x | P/E ratio 2025 * |
26.7
x | Employees | 114,000 |
Yield 2024 * |
2.03% | Yield 2025 * |
2.17% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | -0.03% | ||
1 week | +1.51% | ||
Current month | -5.98% | ||
1 month | -2.86% | ||
3 months | -4.97% | ||
6 months | +14.20% | ||
Current year | -2.92% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +3.79% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 106.9 | -0.03% | 3,112,495 |
24-04-24 | 106.9 | -0.65% | 5,052,691 |
24-04-23 | 107.6 | +0.49% | 3,849,589 |
24-04-22 | 107.1 | -0.20% | 4,948,315 |
24-04-19 | 107.3 | +1.91% | 10,533,616 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+3.83% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+13.05% | 24.8B | |
-1.60% | 24.6B |
- Stock Market
- Equities
- ABT Stock